Literature DB >> 12364739

Validating administrative data in stroke research.

David L Tirschwell1, W T Longstreth.   

Abstract

BACKGROUND AND
PURPOSE: Research based on administrative data has advantages, including large numbers, consistent data, and low cost. This study was designed to compare different methods of stroke classification using administrative data.
METHODS: Administrative hospital discharge data and medical record review of 206 patients were used to evaluate 3 algorithms for classifying stroke patients. These algorithms were based on all (algorithm 1), the first 2 (algorithm 2), or the primary (algorithm 3) administrative discharge diagnosis code(s). The diagnoses after review of medical record data were considered the gold standard. Then, using a large administrative data set, we compared patients with a primary discharge diagnosis of stroke with patients with their stroke discharge diagnosis code in a nonprimary position.
RESULTS: Compared with the gold standard, algorithm 1 had the highest kappa for classifying ischemic stroke, with a sensitivity of 86%, specificity of 95%, positive predictive value of 90%, and kappa=0.82. Algorithm 3 had the highest kappa values for intracerebral hemorrhage and subarachnoid hemorrhage. For intracerebral hemorrhage, the sensitivity was 85%, specificity was 96%, positive predictive value was 89%, and kappa=0.82. For subarachnoid hemorrhage, those values were 90%, 97%, 94%, and 0.88, respectively. Nonprimary position ischemic stroke patients had significantly greater comorbidity and 30-day mortality (odds ratio, 3.2) than primary position ischemic stroke patients.
CONCLUSIONS: Stroke classification in these administrative data were optimal using all discharge diagnoses for ischemic stroke and primary discharge diagnosis only for intracerebral and subarachnoid hemorrhage. Selecting ischemic stroke patients on the basis of primary discharge diagnosis may bias administrative samples toward more benign, unrepresentative outcomes and should be avoided.

Entities:  

Mesh:

Year:  2002        PMID: 12364739     DOI: 10.1161/01.str.0000032240.28636.bd

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  285 in total

1.  Direct oral anticoagulant and antiplatelet combination therapy: Hemorrhagic events in coronary artery stent recipients.

Authors:  Kimon Bekelis; Chiang-Hua Chang; David Malenka; Nancy E Morden
Journal:  J Clin Neurosci       Date:  2018-02-01       Impact factor: 1.961

2.  Distributional Validity and Prognostic Power of the National Institutes of Health Stroke Scale in US Administrative Claims Data.

Authors:  Hamidreza Saber; Jeffrey L Saver
Journal:  JAMA Neurol       Date:  2020-05-01       Impact factor: 18.302

Review 3.  Developing a Conversation Aid to Support Shared Decision Making: Reflections on Designing Anticoagulation Choice.

Authors:  Claudia L Zeballos-Palacios; Ian G Hargraves; Peter A Noseworthy; Megan E Branda; Marleen Kunneman; Bruce Burnett; Michael R Gionfriddo; Christopher J McLeod; Haeshik Gorr; Juan Pablo Brito; Victor M Montori
Journal:  Mayo Clin Proc       Date:  2019-01-11       Impact factor: 7.616

4.  Variation in do-not-resuscitate orders for patients with ischemic stroke: implications for national hospital comparisons.

Authors:  Adam G Kelly; Darin B Zahuranec; Robert G Holloway; Lewis B Morgenstern; James F Burke
Journal:  Stroke       Date:  2014-02-12       Impact factor: 7.914

5.  Comparison of Medicare claims versus physician adjudication for identifying stroke outcomes in the Women's Health Initiative.

Authors:  Kamakshi Lakshminarayan; Joseph C Larson; Beth Virnig; Candace Fuller; Norrina Bai Allen; Marian Limacher; Wolfgang C Winkelmayer; Monika M Safford; Dale R Burwen
Journal:  Stroke       Date:  2014-02-13       Impact factor: 7.914

6.  Risk of a thrombotic event after the 6-week postpartum period.

Authors:  Hooman Kamel; Babak B Navi; Nandita Sriram; Dominic A Hovsepian; Richard B Devereux; Mitchell S V Elkind
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245

7.  The epidemiology of intracerebral hemorrhage in the United States from 1979 to 2008.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2013-08       Impact factor: 3.210

8.  The use of ambulatory blood pressure monitoring among Medicare beneficiaries in 2007-2010.

Authors:  Daichi Shimbo; Shia T Kent; Keith M Diaz; Lei Huang; Anthony J Viera; Meredith Kilgore; Suzanne Oparil; Paul Muntner
Journal:  J Am Soc Hypertens       Date:  2014-09-18

9.  International Classification of Diseases, Ninth Revision (ICD-9) Diagnosis Codes Can Identify Cerebral Venous Thrombosis in Hospitalized Adults.

Authors:  Ava L Liberman; Hooman Kamel; Michael T Mullen; Steven R Messé
Journal:  Neurohospitalist       Date:  2016-05-11

10.  Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study.

Authors:  Sylvie Perreault; Payman Shahabi; Robert Côté; Stéphanie Dumas; Étienne Rouleau-Mailloux; Yassamin Feroz Zada; Sylvie Provost; Ian Mongrain; Marc Dorais; Thao Huynh; Simon Kouz; Ariel Diaz; Mark Blostein; Simon de Denus; Jacques Turgeon; Jeffrey Ginsberg; Jacques Lelorier; Lyne Lalonde; Lambert Busque; Jeannine Kassis; Mario Talajic; Jean-Claude Tardif; Marie-Pierre Dubé
Journal:  Clin Cardiol       Date:  2018-05-15       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.